- Deciphering the age-dependent changes of pulmonary fibroblasts in mice by single-cell transcriptomics
Rundong Wu et al, 2023, Frontiers in Cell and Developmental Biology CrossRef - SARS-CoV-2 diagnosis: a single-centre experience
Ion Maruntelu et al, 2021, Journal of Medicine and Life CrossRef - Healing after COVID-19: are survivors at risk for pulmonary fibrosis?
Lindsay T. McDonald, 2021, American Journal of Physiology-Lung Cellular and Molecular Physiology CrossRef - β-Carboline Alkaloids From the Deep-Sea Fungus Trichoderma sp. MCCC 3A01244 as a New Type of Anti-pulmonary Fibrosis Agent That Inhibits TGF-β/Smad Signaling Pathway
Meng-Jiao Hao et al, 2022, Frontiers in Microbiology CrossRef - Mortality and Its Predictors in COVID-19 Patients With Pre-existing Interstitial Lung Disease
Naveen Dutt et al, 2022, Cureus CrossRef - Pulmonary complications due to COVID-19 – a literature review
Anna Maria Romaszko-Wojtowicz et al, 2021, Polish Annals of Medicine CrossRef - Overview of the pathogenesis of COVID‑19 (Review)
Chao Li et al, 2021, Experimental and Therapeutic Medicine CrossRef - Radiologically suspected COVID‑19‑associated organizing pneumonia responding well to corticosteroids: A report of two cases and a review of the literature
Christos Siafarikas et al, 2022, Experimental and Therapeutic Medicine CrossRef - The Impact of the COVID-19 Pandemic on Dementia Risk: Potential Pathways to Cognitive Decline
Jeffrey D. Pyne et al, 2021, Neurodegenerative Diseases CrossRef - An interpretable deep learning workflow for discovering subvisual abnormalities in CT scans of COVID-19 inpatients and survivors
Longxi Zhou et al, 2022, Nature Machine Intelligence CrossRef - Impact of the COVID-19 Pandemic on Trends in Cardiothoracic Imaging
Kathleen M. Capaccione et al, 2022, Radiology Research and Practice CrossRef - Lung Transplantation in Patients With COVID-19-The Early National Experience
Isabella S. Florissi et al, 2023, Seminars in Thoracic and Cardiovascular Surgery CrossRef - The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections
Ren-Jun Hsu et al, 2022, Frontiers in Immunology CrossRef - A case of successful treatment of diffuse post-coronavirus pulmonary fibrosis with pirfenidone
Svitlana Bychkova et al, 2023, Polish Annals of Medicine CrossRef - Irreversible Lung Transformation Resulting from Damage In COVID-19 — Discourses and Examples of CT Images
A. S. Vinokurov et al, 2022, The Russian Archives of Internal Medicine CrossRef - Prospects for the use of bovhyaluronidase azoxymer in the post-COVID period after a severe COVID-19: A clinical case
Tatiana A. Sergeeva et al, 2023, Psychopharmacology & biological narcology CrossRef - S2k-Leitlinie – Empfehlungen zur stationären Therapie von Patienten mit COVID-19
S. Kluge et al, 2021, Pneumologie CrossRef - The pathogenesis, epidemiology and biomarkers of susceptibility of pulmonary fibrosis in COVID-19 survivors
Andrea Vianello et al, 2022, Clinical Chemistry and Laboratory Medicine (CCLM) CrossRef - The effect of Pirfenidone on pulmonary function parameters in post recovery COVID-19 patients with pulmonary fibrosis compared to placebo in a Government Medical College, West Bengal
Tanmoy Banerjee et al, 2022, Biomedicine CrossRef - Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition
Peng Pi et al, 2023, Frontiers in Pharmacology CrossRef - Respiratorische Viren, COVID und Lungenfibrose – alles wie beim ARDS oder doch anders?
Fotios Drakopanagiotakis et al, 2021, Kompass Pneumologie CrossRef - Dual inhibition of CB1 receptors and iNOS, as a potential novel approach to the pharmacological management of acute and long COVID‐19
Resat Cinar et al, 2022, British Journal of Pharmacology CrossRef - Dynamic role of LMW-hyaluronan fragments and Toll-like receptors 2,4 in progression of bleomycin induced lung parenchymal injury to fibrosis
Apoorva Pandey et al, 2021, The Egyptian Journal of Bronchology CrossRef - Pathogenetic bases of the use of antifibrotic therapy with Bovhyaluronidazum azoximerum in patients with new coronavirus infection COVID-19
O. A. Chernyavskaya et al, 2021, Meditsinskiy sovet = Medical Council CrossRef - Dihydroartemisinin attenuates pulmonary inflammation and fibrosis in rats by suppressing JAK2/STAT3 signaling
Xiaolan You et al, 2022, Aging CrossRef - Cardiopulmonary disease as sequelae of long-term COVID-19: Current perspectives and challenges
Rudolf K. F. Oliveira et al, 2022, Frontiers in Medicine CrossRef - Long‑term effects of COVID‑19 in sickle cell disease: A case report
Ricardo Alberca et al, 2021, World Academy of Sciences Journal CrossRef - Histopathological and molecular links of COVID-19 with novel clinical manifestations for the management of coronavirus-like complications
Ankita Sood et al, 2022, Inflammopharmacology CrossRef - The Atrium in Atrial Fibrillation – A Clinical Review on How to Manage Atrial Fibrotic Substrates
Pedro Silva Cunha et al, 2022, Frontiers in Cardiovascular Medicine CrossRef - Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target
Konstantinos Ntatsoulis et al, 2021, Frontiers in Immunology CrossRef - Materdicine and Medmaterial
Hui HUANG et al, 2022, Journal of Inorganic Materials CrossRef - TRPM7 restrains plasmin activity and promotes transforming growth factor-β1 signaling in primary human lung fibroblasts
Sarah Zeitlmayr et al, 2022, Archives of Toxicology CrossRef - Temporal Patterns of COVID-19-Associated Pulmonary Pathology: An Autopsy Study
George S Stoyanov et al, 2021, Cureus CrossRef - PHYSIOTHERAPY REHABILITATION IN LONG COVID: A CASE SERIES
Khushali Jain et al, 2020, INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH CrossRef - Tracking the time course of pathological patterns of lung injury in severe COVID-19
Thais Mauad et al, 2021, Respiratory Research CrossRef - Pulmonary Fibrosis Progression Prediction Using Image Processing and Machine Learning
Amr Essam Aboeleneen et al, 2021, Emerging Technologies in Biomedical Engineering and Sustainable TeleMedicine CrossRef - mTOR-Inhibition and COVID-19 in Kidney Transplant Recipients: Focus on Pulmonary Fibrosis
Simona Granata et al, 2021, Frontiers in Pharmacology CrossRef - Gamma Delta T Cells and Their Involvement in COVID-19 Virus Infections
Georg von Massow et al, 2021, Frontiers in Immunology CrossRef - Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study
Álvaro Romero-Duarte et al, 2021, BMC Medicine CrossRef - Mesenchymal Stromal/Stem Cells and Their Extracellular Vesicles Application in Acute and Chronic Inflammatory Liver Diseases: Emphasizing on the Anti-Fibrotic and Immunomodulatory Mechanisms
Ali Hazrati et al, 2022, Frontiers in Immunology CrossRef - Prospects of Hyaluronidase Therapy in Novel COVID-19 Infection with Damage to Lungs
Aleksandra V. Solov’yeva et al, 2022, I.P. Pavlov Russian Medical Biological Herald CrossRef - Pathogenesis of pulmonary fibrosis
M.G. Rybakova et al, 2024, Russian Journal of Archive of Pathology CrossRef - Post-COVID-19 Pulmonary Fibrosis
Asma Mohammadi et al, 2022, Cureus CrossRef - Pulmonary Manifestations of COVID-19
Sivakumar Nagaraju et al, 2024, Textbook of SARS-CoV-2 and COVID-19 CrossRef - PTPα promotes fibroproliferative responses after acute lung injury
Yael Aschner et al, 2022, American Journal of Physiology-Lung Cellular and Molecular Physiology CrossRef